Introduction {#s1}
============

The evolution of new genes through duplication-divergence processes is well understood ([@bib10]; [@bib24]; [@bib39]; [@bib59]). But the evolution of new genes from non-coding DNA has been little considered for a long time ([@bib58]). However, with the increasing availability of comparative genome data from closely related species, more and more cases of unequivocal de novo gene emergence have been described ([@bib41]; [@bib55]; [@bib58]; [@bib59]). These analyses have shown that de novo gene emergence is a very active process in all evolutionary lineages analyzed. A comparative analysis of closely related mouse species has even suggested that virtually the whole genome is 'scanned' by transcript emergence and loss within about 10 million years of evolutionary history ([@bib46]).

But unlike the detection of the transcriptional and translational expression of de novo genes, functional studies of such genes have lacked behind. In yeast, the de novo evolved gene *BSC4* was found to be involved in DNA repair ([@bib6]) and *MDF1* ([@bib35]; [@bib36]) was found to suppress mating and to promote fermentation. Knockdown of candidates of de novo genes in *Drosophila* have suggested effects on viability and male fertility ([@bib9]; [@bib52]). Male fertility was also found to be affected for *Pldi* in mice, which codes for a lncRNA. In this case the knockout was shown to affect sperm motility and testis weight ([@bib23]). There is generally a tendency to focus on male testis effects for newly evolved genes. However, considering that the mammalian females have complex reproduction cycles, including morphology, physiology and behavior relating to mate choice, pregnancy, and parenting, de novo genes in mammals should also be expected to have a function in female-specific organs and affect female fertility and reproductive behavior as well.

Here, we have first generated a list of candidate genes that have evolved in the lineage of mice, after they split from rats. We have analyzed ribosome profiling and mass spectrometry data for these and find that most of them are translated. From this list, we have then chosen a gene specifically expressed in the female reproductive system to address the question of the role of de novo gene evolution in this as yet little studied context. We used a knockout line for the reading frame of the gene, created through CRISPR/Cas9-mediated frameshift mutagenesis, and subjected it to extensive molecular and phenotypic analysis. We conclude that it functions in the oviduct and affects female fertility cycles and that its emergence may have been driven by an evolutionary conflict situation. Given that we find no measurable acceleration of sequence evolution in the gene, we conclude that it became directly functional after its open reading frame became functional. These results support the notion that random protein sequences have a good probability for conveying evolutionarily relevant functions ([@bib44]).

Results {#s2}
=======

De novo evolved genes in the mouse genome {#s2-1}
-----------------------------------------

To identify candidates for recently evolved de novo genes, we have applied a combined phylostratigraphy and synteny-based approach. We were able to identify 119 predicted protein-coding genes from intergenic regions that occur only in the mouse genome, but not in rats or humans. We re-assembled their transcript structures and estimated their expression levels using available ENCODE RNA-Seq data in 35 tissues from the mouse ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). To validate that their predicted open reading frames (ORFs) are indeed translated, we have searched ribosome profiling and peptide mass spectrometry datasets ([Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). We found for 110 out of the 119 candidate genes direct evidence for translation.

![Transcriptional abundance and structural features of 119 candidate de novo genes in the mouse lineage.\
(**A**) Transcriptional abundance in each mouse tissue, represented as the sum of log-transformed FPKM values of each transcript: sum(log2(FPKM + 1)). Details on tissue designations and RNA samples are provided in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. The five tissues with the highest fractions are highlighted in red and the lowest ones in blue. (**B**) Comparison of overall expression levels (represented as the highest FPKM values in the 35 tissues) between de novo and all other protein-coding genes ('De novo' and 'Other' on the x-axis). (**C**) Comparison of averages of intrinsic structural disorder scores between de novo and all other protein-coding genes. (**D**) Comparison of fractions of sequence covered by hydrophobic clusters between de novo and all other protein-coding genes.\
10.7554/eLife.44392.004Figure 1---source data 1.Excel file with five tabs, providing (i) the legends for the tissue sources, (ii) the table for the gene lists, (iii) the information for the reassembled transcripts, (iv) the proteomic evidence shown in detail, and (v) the accession numbers for the ENCODE data.](elife-44392-fig1){#fig1}

Expression of these genes is found throughout all tissues analyzed, with notable differences. Testis and brain express the relatively largest abundance of these candidate de novo genes, while the digestive system and liver express the lowest ([Figure 1A](#fig1){ref-type="fig"}). Expression levels of these genes are generally lower than those of other protein-coding genes (FPKM medians: 0.63 vs. 8.18; two-tailed Wilcoxon rank sum test, p-value\<2.2 × 10^−16^; [Figure 1B](#fig1){ref-type="fig"}). Most overall molecular patterns are similar to previous findings ([@bib45]; [@bib56]; [@bib66]). They have fewer exons (medians: 2 vs. 7; two-tailed Wilcoxon rank sum test, p-value\<2.2 × 10^−16^) and fewer coding exons than other protein-coding genes (medians: 1 vs. 6; two-tailed Wilcoxon rank sum test, p-value\<2.2 × 10^−16^). The lengths of their proteins are shorter than those of other proteins (medians: 125 vs. 397; two-tailed Wilcoxon rank sum test, p-value\<2.2 × 10^−16^). However, their proteins are predicted to be less disordered than other proteins (medians: 0.20 vs. 0.27; two-tailed Wilcoxon rank sum test, p-value=0.0024; [Figure 1C](#fig1){ref-type="fig"}) and equally hydrophobic to other proteins (medians: 0.56 vs. 0.57; two-tailed Wilcoxon rank sum test, p-value=0.52; [Figure 1D](#fig1){ref-type="fig"}), but note that the two sets of values show a broad distribution.

Analysis of a female expressed gene {#s2-2}
-----------------------------------

To study the function of a gene expressed in the female reproductive tract, we picked *Gm13030* ([Figure 2](#fig2){ref-type="fig"}) from the above list for in-depth analyses, including evolutionary history, reading-frame knockout, transcriptomic studies and phenotyping. According to the ENCODE RNA-Seq data, *Gm13030* is only expressed in two tissues, the ovary of 8 weeks old females (FPKM 0.135), as well as the subcutaneous adipose tissue of 8 weeks old animals (FPKM 0.115) ([Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). Given that the ovary is a small organ, with closely attached tissues, such as oviduct and gonadal fat pad, there could be contamination between these different tissue types. Hence, we were interested whether there is specificity for one of them. We used reverse transcription PCR on RNA from the respective carefully prepared tissue samples, to trace the expression of *Gm13030* and a control gene (*Uba1*). We found that *Gm13030* is not expressed in the ovary, but predominantly in the oviduct with only a weak signal from the adjacent fat pad ([Figure 2B](#fig2){ref-type="fig"}).

![General information of *Gm13030*, expression, and knockout strategy.\
(**A**) General information on transcript ID, location and protein characteristics. (**B**) Reverse transcription PCR across intron junctions to study *Gm13030* expression in gonadal fat pad, ovary, oviduct, and uterus. Fat: gonadal fat pad; M: marker (from top to bottom: 1500 bp, 850 bp, 400 bp, 200 bp, 50 bp); U: *Uba1* (control gene, 255 bp); j1: *Gm13030* junction 1 (161 bp); j2: *Gm13030* junction 2 (209 bp). (**C**) Transcript structure, DNA target, guide RNA, and depiction of the deletion created by the CRISPR/Cas9 knockout of *Gm13030*. The 20-nt guide sequence is colored blue and the 3-nt PAM is colored red. The induced deletion was verified by sequencing.](elife-44392-fig2){#fig2}

Evolutionary analysis of *Gm13030* {#s2-3}
----------------------------------

To trace the evolutionary emergence of *Gm13030*, we used available whole genome information of different mouse species to generate alignments, combined with Sanger sequencing data of PCR fragments from mouse populations, subspecies, and related species from the genus *Mus*. We found the respective genomic region covering the ORF in all mouse species analyzed. It is not possible to identify an unequivocal orthologous region in the rat, because the unique genomic region in the mouse matches with multiple diverged genomic fragments in the rat reference genome, and all these fragments overlap only marginally with the mouse region.

The alignments for the whole coding region allowed us to infer mutations that have led to the opening of the reading frame (enabler mutations), as well as further substitutions and secondary disablers along the tree topology ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The most distant species in which we can trace the orthologous genomic region, *M. pahari*, lacks part of the coding region. Two further outgoup species, *M. matheyi* and *M. caroli* have an orthologous genomic region that spans the whole reading frame, but harbor stop codons at position 204 and 258 of the alignment ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). At position 258 we find a change from TG**A** to TG**C** in all ingroup species, that is this is a clear enabler mutation. The same change is seen at position 204, but some of the ingroup species that show also secondary disablers (see below) retain the TGA. But since both enabler mutations are at least seen in *M. spicilegus*, we place the emergence of the *Gm13030* ORF at this node, that is between 2--4 million years ago. [Figure 3](#fig3){ref-type="fig"} includes all coding and non-coding substitutions that have occurred beyond this node. This includes secondary disablers in *M. spretus*, as well as *M. m. domesticus*. Most notably, all three *M. m. domesticus* populations carry a 17nt deletion that leads to a disruption of the reading frame. They share also several other substitutions, not only among them, but also with *M. spretus* and *M. spicilegus,* suggesting a secondary introgression effect ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Hence, after the emergence of the *Gm13030* ORF, only the *M. m. musculus* and *M. m. castaneus* populations have retained it.

![Evolutionary history of the *Gm13030* ORF.\
The tree is based on the alignments shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, with only *M. caroli* included as the outgroup. The relevant substitutions at the different nodes are shown in boxes. Numbers refer to coding:non-coding substitutions, 'stop' refers to a mutation that creates a stop codon in the reading frame, 'DEL' refers to a deletion, 'INT' to an assumed introgression. 3-letter codes on the tips refer to the different populations of the respective sub-species. Expected substitutions on the top are inferred from whole genome distances and represent the approximately neutral number of substitutions for the respective comparisons ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).](elife-44392-fig3){#fig3}

When focusing on the substitutions that occurred within the lineage towards *M. m. musculus*, we find a total of 7 coding and six non-coding substitutions. Hence, the total number of substitutions is slightly higher than the 6--7 expected for approximately neutral substitutions from a genomic average between these populations (indicated on top of [Figure 3](#fig3){ref-type="fig"}), but there is no bias towards coding mutations. Overall, there are too few mutations to apply a dN/dS test and the ratios of non-coding to coding mutations are all non-significant ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Hence, we conclude that there is no traceable signal of positive selection on the protein after the emergence of the ORF.

Generation of gene knockout and off-target analysis {#s2-4}
---------------------------------------------------

For the further functional characterization of *Gm13030*, we obtained a knockout line with a frameshift in the ORF through CRISPR/Cas9 mutagenesis. The knockout line is from a laboratory strain that is nominally derived from *Mus musculus domesticus* (C57BL/6N). However, as stated above, *Mus musculus domesticus* populations have disabling mutations. But C57BL/6N is known to carry also alleles from *Mus musculus musculus* ([@bib68]) and the *Gm13030* allele represents indeed the non-interrupted version that is found in *M. m. musculus* and *M. m. castaneus*. The CRISPR/Cas9 treatment introduced a 7 bp deletion at the beginning of the ORF (position 41--47) causing a frameshift and a premature stop codon in exon 2 ([Figure 2C](#fig2){ref-type="fig"}).

The CRISPR/Cas9 experiment to generate our knockout line might have generated potential off-target mutations. In order to rule out this possibility, we performed whole genome sequencing on both animals of our founding pair. The female and male of our founding pair were selected from the first-generation offspring of the mating among mosaic and wildtype mice which were directly developed from the zygotes injected. Each of them contained the 7 bp deletion allele described above and a wildtype allele. If there were any off-target sites, they should exist as heterozygous or homozygous indels or single nucleotide variants. However, in our genome sequencing results, we found no variant located in the 100 bp regions around the genome-wide 343 predicted off-target sites. Further, we manually checked the reads mapped to the regions around the top 20 predicted sites in both samples and none of them yielded an indication of variants.

Knockout effect on the transcriptome {#s2-5}
------------------------------------

The *Gm13030* knockout line is homozygous viable and fertile. We were therefore interested in studying the impact on the transcriptional network in the tissue in which *Gm13030* is predominantly expressed. Given the observation that *Gm13030* is specifically expressed in adult oviducts, we focused the RNA-Seq analysis on the oviducts of 12 homozygous knockout and 12 wildtype females (10--11 weeks old). There were on average 75.9 million unique mapped reads per sample (range from 57.5 to 93.0 million reads; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The genotypes of the 24 samples were further confirmed by the reads covering the sites in which the 7-bps deletion locates ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In the initial analysis involving all samples, we found no differentially expressed gene between knockouts and wildtypes.

However, given that the expression in oviducts should be fluctuating according to estrous cycle, we clustered the transcriptomes of the individuals based on both principle component analysis (PCA) and hierarchical clustering methods, which allowed to distinguish three major clusters ([Figure 4A and B](#fig4){ref-type="fig"}). To confirm that these correspond to three different phases of the estrous cycle, we analyzed the expression of three known cycle dependent genes in the respective clusters, progesterone receptor (*Pgr*) and estrogen receptors (*Esr1* and *Gper1*). We found that these genes change indeed in the expected directions, both in the wildtype as well as the knockout animals ([Figure 4C--E](#fig4){ref-type="fig"}).

Based on this finding, we performed the differential expression analysis on the three clusters separately. We found 21 differentially expressed genes in cluster 1 (DESeq2, adjusted p-value≤0.01; fold changes range from 0.75 to 1.59; [Table 1](#table1){ref-type="table"}), but still none for clusters 2 and 3. The 21 differentially expressed genes in cluster 1 do not include the genes neighboring *Gm13030* (*Pla2g2e* and *Pla2g5*). This suggests that *Gm13030* acts during the phase of high progesterone receptor and estrogen receptor 1 expression, and low G protein-coupled estrogen receptor 1 expression, corresponding to proestrus or the starting of estrus, that is, the phase where females start to become receptive for implantation.

![Clusters and expression levels in the 24 RNA-Seq samples of oviducts.\
(**A**) PC1 values from the PCA analysis, (**B**) hierarchical clustering result. Sample codes and genotypes are listed along X-axis. The 24 samples are assigned into three clusters accordingly. (**C-E**) The expression levels of three sex hormone receptor genes (*Pgr*, *Esr1*, *Gper1*) are shown by box plots.](elife-44392-fig4){#fig4}

10.7554/eLife.44392.014

###### Differentially expressed genes in oviduct cluster 1.

  Gene ID              Gene name    Base mean^a^   Fold change   Adjusted P-Value
  -------------------- ------------ -------------- ------------- ------------------
  ENSMUSG00000057417   *Dcpp3*      3700           1.59          0.0000
  ENSMUSG00000096278   *Dcpp2*      427            1.47          0.0000
  ENSMUSG00000096445   *Dcpp1*      415            1.45          0.0000
  ENSMUSG00000034009   *Rxfp1*      4410           1.35          0.0003
  ENSMUSG00000022206   *Npr3*       349            1.36          0.0011
  ENSMUSG00000035864   *Syt1*       666            1.34          0.0011
  ENSMUSG00000070348   *Ccnd1*      7382           0.80          0.0012
  ENSMUSG00000058897   *Col25a1*    1605           1.34          0.0015
  ENSMUSG00000059908   *Mug1*       268            1.35          0.0015
  ENSMUSG00000063130   *Calml3*     698            1.31          0.0018
  ENSMUSG00000015966   *Il17rb*     637            0.75          0.0025
  ENSMUSG00000022358   *Fbxo32*     3614           1.31          0.0038
  ENSMUSG00000040724   *Kcna2*      895            0.75          0.0038
  ENSMUSG00000061477   *Rps7*       6247           1.20          0.0052
  ENSMUSG00000067786   *Nnat*       658            1.32          0.0052
  ENSMUSG00000019987   *Arg1*       1208           1.32          0.0068
  ENSMUSG00000079017   *Ifi27l2a*   1065           1.32          0.0073
  ENSMUSG00000028031   *Dkk2*       678            1.31          0.0077
  ENSMUSG00000022037   *Clu*        17139          1.22          0.0086
  ENSMUSG00000033715   *Akr1c14*    23879          1.21          0.0086
  ENSMUSG00000034039   *Prss29*     176            1.29          0.0086

^a^The mean of the normalized read counts for all cluster one samples.

The top three differentially expressed genes belong all to a single young gene family, namely *Dcpp1*, *Dcpp2* and *Dcpp3,* all three of which were significantly up-regulated in the knockout samples (DESeq2, fold changes: 1.45 for *Dcpp1*, 1.47 for *Dcpp2*, and 1.59 for *Dcpp3,* [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). These genes are expressed in female and male reproductive organs and the thymus, and were previously found to function in oviducts to stimulate pre-implantation embryo development ([@bib33]). Given the special importance of the expression differences for the *Dcpp* genes, we confirmed them by a quantitative PCR assay ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The fourth gene in the list of significantly changed expression is *Rxfp1*, the receptor for the pregnancy hormone relaxin. Relaxin signaling is involved in a variety of cellular processes ([@bib61]), whereby the regulation of the reproductive cycle is one of them ([@bib1]).

Knockout phenotype {#s2-6}
------------------

Given that the *Dcpp* genes are more highly expressed in the knockouts, one could predict a higher implantation frequency of embryos, as it has been shown through experimental manipulation of *Dcpp* levels ([@bib33]). We assessed the litters of pairs that were produced from our normal breeding stocks and found that the first litters from homozygous knockout females were produced after the same time as those from wildtype or heterozygous females (medians: 23 vs. 22 days, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). However, we saw a major difference with respect to the second litter. Homozygous knockout females tended to produce this faster than wildtype or heterozygous females (medians: 23 vs. 38 days, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). To test this observation directly, we set up additional 10 mating pairs of homozygous knockout females with wildtype males and 10 wildtype pairs for control, all at approximately the same age at the start (8--9 weeks old). We found that the knockout and wildtype pairs had their first litter after the same time (medians: 23 vs. 22 days, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}), while the knockout females had their second litter after a shorter time (medians: 24 vs. 36 days, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}), thus confirming the initial observation. However, the data have to be seen in the context of the non-continuous nature of pregnancy, caused by the ovulation cycles of females. Females can ovulate within a day of giving birth, but if no successful mating occurs at that time, ovulation is suppressed while the female is lactating. This results in a delay in the timing of the next pregnancy. [Figure 5](#fig5){ref-type="fig"} shows that this pattern is also evident in our data.

![Distributions of the time from the first litter to the second litter.\
Time points of the second litter are plotted for the different genotypes, with box plots marked. A bimodal distribution becomes evident, as discussed in the text.\
10.7554/eLife.44392.016Figure 5---source data 1.Details of the fertility scores for the different groups of mice.The mice listed under the UC codes are part of the standard stock breeding, the mice listed under the WT and KO codes were specifically set up to confirm the observations from the stock breeding.](elife-44392-fig5){#fig5}

We found that the times to the second litter were either smaller than or equal to 25 days (early group) or larger than or equal to 35 days (late group) for both the homozygous knockout females and the wildtype or heterozygous females. But in the homozygous knockouts, we saw more in the early group, leading to the median values having a big difference. When using the two-tailed Wilcoxon rank sum test which does not require the assumption of a normal distribution, we found that this difference is significant when calculated across all breeding data (p-value=0.042).

Interestingly, we found not only a timing difference for the second litter but also infanticide in about a quarter of the litters (4 out of 16) from homozygous females, but none in wildtype or heterozygous females (two-tailed Fisher\'s exact test, p-value=0.031, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). This could indicate that when the second litter follows too quickly, the females may be under stronger postpartum stress resulting in partial killing of pups. In addition, one could also have expected to see homozygous knockout females having larger litter sizes than those of wildtype or heterozygous females, but they were almost the same (medians: 6.5 vs. 7.0 for littler 1 and 6.5 vs. 7.5 for litter 2, [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). One possible explanation is that considering the high infanticide rate for homozygous knockouts, more pups from homozygous knockout females were eaten before being observed.

These results suggest that the loss of *Gm13030* should be detrimental to the animals in the wild. Still, we see that the *M. m. domesticus* populations have secondarily lost this gene ([Figure 3](#fig3){ref-type="fig"}). Intriguingly, when inspecting the copy number variation data that we have produced previously ([@bib51]), we found that *Dcpp3* was also lost in *M. m. domesticus* populations ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Under the assumption that this results in an overall lowered expression of *Dcpp* RNAs, it could be considered to compensate for the loss of *Gm13030*.

Discussion {#s3}
==========

The aim of this study was to trace the possible functions of a gene that has evolved only very recently out of an intergenic region. Out of a list of 119 candidate genes that have evolved de novo ORFs in the mouse lineage, we have chosen a gene specifically expressed in the female reproductive system for detailed molecular and functional analysis. We have used CRISPR/Cas9 induced frameshift mutation within the ORF to obtain the knockout line. This implies that it is indeed the protein, rather than the RNA that is functional. We find that the knockout has an impact on the transcriptome in the oviduct only at a specific stage of the female estrous cycle, and we also find a unique female-specific phenotype. Hence, we propose to give a formal name to *Gm13030*. We name it after a female figure, *Shiji* (*Shj*), who was born from stone (de novo) as a mythology character in the Chinese traditional novel *Investiture of the Gods* (*Fengshen Yanyi*), which was published in the 16th century.

Transcriptome and phenotype changes {#s3-1}
-----------------------------------

The knockout line did not show an overt phenotype, but we considered this also as a priori unlikely, given that a de novo evolved gene is expected to be only added to an existing network of genes ([@bib70]). But given the observed transcriptome changes in the oviducts, we were encouraged to apply the fertility test. We identified a possible direct link between the identified phenotype of a shorter interval to second birth in the knockouts and the transcriptomic changes. We found that the expression level of all three copies of *Dcpp* genes in C57BL/6N mice is enhanced in the *Shj* knockout animals. *Dcpp* expression is induced in the oviduct by pre-implantation embryos and is then secreted into the oviduct. This in turn stimulates the further maturation of the embryos and eventually the implantation ([@bib33]). Hence, this is a system where a selfish tendency for *Dcpp* expression favoring embryo implantation could develop, in expense of the interest of the mother that wants to build up new resources first. Accordingly, *Shj* could have found its function in controlling this expression, that is, 'defending' the interests of the mother. Intriguingly, the secondary loss of *Shj* in *M. m. domesticus* populations is accompanied by a loss of *Dccp3* in the same populations. This is compatible with the notion that an evolutionary conflict of interest exists for these interactions, whereby it remains open whether the loss of *Dcpp3* preceded the loss of *Shj* or vice versa. We note that *Shj* inactivation alleles segregate also in the populations of the other subspecies (*M. m. musculus* and *M. m. castaneus*) in low frequency, implying that the evolutionary process of fully integrating this new gene is still ongoing.

Male bias versus female bias {#s3-2}
----------------------------

There has so far been much focus on de novo genes and other new genes to have male-biased expression and to affect male fertility ([@bib10]; [@bib17]; [@bib23]; [@bib24]; [@bib39]; [@bib52]; [@bib71]). Only recently, one of a pair of duplicated genes in *Drosophila*, *Arts*, has been shown to have high expression in the ovary and to affect fertility ([@bib63]). Here we have shown that a de novo gene specifically expressed in the female reproductive tract affects the female fertility cycle. Female reproduction should be subject to accelerated evolution patterns, especially in mammals which have high complexities in female reproduction, including mate choice, pregnancy, and parenting, which has been neglected so far. One reason is that the estrous cycle in females adds to the complexity of the analysis. Our clustering analysis of the transcriptomic data, which considers the stages of estrous cycle, provides an approach for studying biased gene expression in female mammals as well. Another reason for the current focus on males is the large number of new genes that are transcribed in testis. However, this is due to the promiscuous phase of expression in meiotic cells, where many genes use alternative promotors ([@bib29]). These meiotic cells are abundant in testis, but are difficult to analyze in ovaries. Hence, it is still open whether there might be a similar phase of over-expression of new genes in female meiotic stages as well.

*Shj* exerts its effects in somatic cells, that is, independent of a possible expression in meiosis, but in the context of a possible selfish gene conflict situation, which has so far been ascribed mostly to the male reproductive system ([@bib30]). Hence, we expect that a better analysis of female-specific expression of genes should reveal more evolutionary interesting insights in the future.

Functional de novo gene emergence {#s3-3}
---------------------------------

It has long been assumed that the emergence of function out of non-coding DNA regions must be rare, and if it occurs, the resulting genes would be far away from assuming a function. Our results do not support these assumptions. It is possible to find many well supported transcripts that could be considered to be true de novo genes. We have shown here that *Shj* has functions on the transcriptome and the phenotype. In fact, we have initial data for two additional de novo genes expressed in the brain and limbs, where knockouts produce an effect on the transcriptome and show subtle phenotypes (data available on bioRxiv [doi.org/10.1101/510214](http://doi.org/10.1101/510214)). However, since lacZ replacement constructs were used instead of CRISPR-induced knockouts, it remains still open whether the effects are due to the new ORFs or to chromatin effects caused by the deletion constructs. This will need further analysis.

The *Shj* ORF has acquired only a small number of additional substitutions, both coding and non-coding after it emerged. This suggests that it did not need additional adaptation of the protein sequence to become functional. This is in line with a similar analysis on a larger set of de novo ORFs in the mouse ([@bib54]). Hence, this raises the question whether we should necessarily expect signatures of positive selection around de novo genes as part of proof that it is a true gene ([@bib41]). Alternatively, given the observation that a large set of expressed random sequences can exert phenotypes ([@bib3]; [@bib44]), it would seem more likely that the conversion of a non-coding region into a coding one would already be sufficient to create a gene function. In the early phase of evolution, such genes would likely be frequently subject to secondary loss ([@bib48]), but they could eventually also become fixed and then further evolutionarily optimized.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\           Designation                              Source or\   Identifiers                  Additional\
  or resource                                                                reference                                 information
  --------------------------------- ---------------------------------------- ------------ ---------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  Gene (*Mus musculus*)             *Gm13030*; *Shj*                         NA           Ensembl:ENSMUSG00000078518   

  Genetic reagent (*M. musculus*)   *Gm13030* line                           this paper                                Generated from C57BL/6N line by introducing a 7 bp deletion using CRISPR/Cas9 at Mouse Biology Program (MBP). See detail in Materials and methods.

  Sequence-based reagent            Reverse transcription PCR primers        this paper                                See Materials and methods.

  Sequence-based reagent            PCR and Sanger sequencing primers        this paper                                See Materials and methods.

  Sequence-based reagent            Genotyping primers                       this paper                                See Materials and methods.

  Sequence-based reagent            Droplet digital PCR primers and probes   this paper                                See Materials and methods.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ethics statement {#s4-1}
----------------

The mouse studies were approved by the supervising authority (Ministerium für Energiewende, Landwirtschaftliche Räume und Umwelt, Kiel) under the registration numbers V244-71173/2015, V244-4415/2017 and V244-47238/17. Animals were kept according to FELASA (Federation of European Laboratory Animal Science Association) guidelines, with the permit from the Veterinäramt Kreis Plön: 1401--144/PLÖ−004697. The respective animal welfare officer at the University of Kiel was informed about the sacrifice of the animals for this study.

Genome-wide identification of de novo genes {#s4-2}
-------------------------------------------

We modified previous phylostratigraphy and synteny-based methods to identify *Mus*-specific de novo protein-coding genes from intergenic regions. Note that while the phylostratigraphy based approach was criticized to potentially include false positives ([@bib42]), we have shown that the problem is relatively small and that it is in particularly not relevant for the most recently diverged lineages within which de novo gene evolution is traced ([@bib15]). We started with mouse proteins annotated in Ensembl (Version 80) ([@bib69]) (1) with protein length not smaller than 30 amino acids, (2) with a start codon at the beginning of the ORF, (3) with a stop codon at the end of the ORF, (4) without stop codons within the annotated ORF. For the phylostratigraphy-based strategy, in order to save computational time, we first used NCBI BLASTP (2.5.0+) to align low complexity region masked mouse protein sequences to rat protein sequences annotated in Ensembl (Version 80) and filtered out the mouse sequences having hits with E-values smaller than 1 × 10^−7^. Next we used NCBI BLASTP (2.5.0+) to align the remaining low complexity region masked sequences to NCBI nr protein sequences (10 Nov. 2016) ([@bib47]) and filtered out the mouse sequences having non-genus *Mus* hits with E-values smaller than 1 × 10^−3^ according to [@bib45].

The genes remaining after these filtering steps are the candidates for the de novo evolved genes. In order to deal also with proteins having low complexity regions, we further applied a synteny-based strategy on the rest proteins by taking advantage of the Chain annotation from Comparative Genomics of UCSC Genome Browser (<http://genome.ucsc.edu/>) ([@bib26]). We filtered out the proteins encoded on unassembled scaffolds because their chromosome information is not compatible between Ensembl and UCSC annotations. We only compared rat and human proteins with mouse proteins because their genomes are well assembled and genes are well annotated. We performed the same procedures on rat and human data separately, and used 'mm10.rn5.all.chain' and 'rn5ToRn6.over.chain' from UCSC and gene annotation from Ensembl (Version 80) for rat, and 'mm10.hg38.all.chain' from UCSC and gene annotation from Ensembl (Version 80) for human. For each mouse gene, if its ORF overlaps with any ORFs in the rat or human mapping regions in Chain annotation, we aligned its protein sequence to those protein sequences with program water from EMBOSS (6.5.7.0) ([@bib53]); if one of the alignment scores is not smaller than 40, we filtered out the protein. The remaining 119 genes are the candidates for the following analysis and the pool for us to select the gene for further functional experiments.

ENCODE RNA-Seq analysis {#s4-3}
-----------------------

We downloaded the raw read files of 135 strand-specific paired-end RNA-Seq samples generated by the lab of Thomas Gingeras, CSHL from ENCODE ([@bib18]; [@bib57]) including 35 tissues from different organs and different developmental stages, and each of them had multiple biological or technical replicates. We trimmed the raw reads with Trimmomatic (0.35) ([@bib5]), and only used paired-end reads left for the following analyses. We mapped the trimmed reads to the mouse genome GRCm38 ([@bib65]; [@bib69]) with HISAT2 (2.0.4) ([@bib28]) and SAMtools (1.3.1) ([@bib34]), and took advantage of the mouse gene annotation in Ensembl (Version 80) by using the `--ss` and `--exon` options of `hisat2-build`. We assembled transcripts in each sample, and merged annotated transcripts in Ensembl (Version 80) and all assembled transcripts with StringTie (1.3.4d) ([@bib50]). Then we estimated the abundances of transcripts, FPKM values, in each sample with StringTie (1.3.4d). For each tissue, we summarized the FPKM values of each transcript by averaging the values from multiple biological or technical replicates; and if a gene has multiple transcripts, we assigned the summary of the FPKM values of the transcripts as the transcriptional abundance of the gene.

Ribosome profiling and proteomics analysis {#s4-4}
------------------------------------------

We downloaded the datasets that included both strand-specific ribosome profiling (Ribo-Seq) and RNA-Seq experiments of the same mouse samples from Gene Expression Omnibus ([@bib4]) under accession numbers GSE51424 ([@bib20]), GSE72064 ([@bib11]), GSE41426 ([@bib14]), GSE22001 ([@bib21]), GSE62134 ([@bib13]), and GSE50983 ([@bib8]), which corresponded to brain, hippocampus, neural ES cells, heart, skeletal muscle, neutrophils, splenic B cells, and testis. Ribo-seq datasets were depleted of possible rRNA contaminants by discarding reads mapped to annotated rRNAs, and then the rest reads were mapped to GRCm38 ([@bib65]; [@bib69]) with Bowtie2 (2.1.0) ([@bib32]). RNA-Seq reads were mapped to the mouse genome GRCm38 with TopHat2 (2.0.8) ([@bib27]). Then we applied RiboTaper (1.3) ([@bib7]) which used the triplet periodicity of ribosomal footprints to identify translated regions to the bam files. Mouse GENCODE Gene Set M5 (Ensembl Version 80) ([@bib43]) was used as gene annotation input. The Ribo-seq read lengths to use and the distance cutoffs to define the positions of P-sites were determined from the metaplots around annotated start and stop codons as shown below.

SampleRead lengthsOffsetsBrain29,3012,12Hippocampus29,3012,12Neural ES cells27,28,29,3012,12,12,12Heart29,3012,12Skeletal muscle29,3012,12Neutrophils25,26,27,28,29,30,31,32,3312,12,12,12,12,12,12,12,12Splenic B cells30,3112,12Testis2812

All mouse peptide evidence from large-scale mass spectrometry studies was retrieved from PRIDE (09 Aug. 2015) ([@bib64]) and PeptideAtlas (31 Jul. 2015) ([@bib12]) databases. We performed the same procedures on PRIDE and PeptideAtlas data separately following the method described in [@bib67]. In brief, if the whole sequence of a peptide was identical to one fragment of the tested de novo protein sequence, and had at least two amino acids difference compared to all the fragments of other protein sequences in the mouse genome, the peptide was considered to be convincing evidence for the translational expression of the respective de novo protein.

Molecular patterns of de novo genes {#s4-5}
-----------------------------------

The exon number of a gene was assigned as the exon number of the transcript having highest FPKM value among all the transcripts of the gene. The intrinsic structural disorder of proteins was predicted using IUPred ([@bib16]), long prediction type was used. The intrinsic structural disorder score of a protein was assigned as the average of the scores of all its amino acids. The hydrophobic clusters of proteins were predicted using SEG-HCA ([@bib19]), and then the fraction of the sequence covered by hydrophobic clusters for each protein was calculated. 'Other' genes used to compare against the de novo protein-coding genes were the protein-coding genes annotated in Ensembl (Version 80) excluding the de novo genes.

Reverse transcription PCR {#s4-6}
-------------------------

The ovaries, oviducts, uterus, and gonadal fat pad from the females from the *Gm13030* line were carefully collected and immediately frozen in liquid nitrogen. Total RNAs from those tissues were purified using QIAGEN RNeasy Microarray Tissue Mini Kit (Catalog no. 73304), and the genomic DNAs were removed using DNase I, RNase-free (Catalog no. 74106). The first strand cDNAs were synthesized using the Thermo Scientific RevertAid First Strand cDNA Synthesis Kit (Catalog no. K1622) by targeting poly-A mRNAs with oligo dT primers. Two pairs of primers targeted on the two junctions of *Gm13030* gene structure and a pair of primers targeted on a control gene *Uba1* were used. The sequences of the primers are shown below. PCR was done under standard conditions for 38 cycles.

Primer nameSequence (5'\>3')junc1_FGGACACAGGCCAGGGAAATGjunc1_RCCTTAGGCCTTGCGAAGGAAjunc2_FGCCTGCTTTCACCATTTCAGGjunc2_RTATGAAAGGCTGGGTGAGGTGUba1_FGAAGATCATCCCAGCCATTGUba1_RTTGAGGGTCATCTCCTCACC

Genomic DNA sequences of the *Gm13030* locus {#s4-7}
--------------------------------------------

The genomic sequences from wild mice *M. spretus* (eight individuals), *M. m. castaneus* (TAI, 10 individuals), *M. m. musculus* from Kazakhstan (KAZ, eight individuals), *M. m. musculus* from Afghanistan (AFG, six individuals), *M. m. musculus* from Czech Republic (CZE, eight individuals), *M. m. domesticus* from Iran (IRA, eight individuals), *M. m. domesticus* from Germany (GER, 11 individuals), and *M. m. domesticus* from France (FRA, eight individuals) were retrieved from the whole genome sequencing data in [@bib22]. The genomic sequences from mouse strains CAROLI/EiJ (*M. caroli*) and PAHARI/EiJ (*M. pahari*) were retrieved from the whole genome sequencing data in [@bib60]. For all these sequences, we manually checked and corrected the substitutions based on the original mapped reads.

The genomic sequences from wild mice *M. mattheyi* (four individuals) and *M. spicilegus* (four individuals) were determined by Sanger sequencing of the PCR fragments from the genomic DNAs purified with salt precipitation. The PCR primers listed below were designed according to the whole genome sequencing data in [@bib46].

FragmentDirectionSequence (5'\>3')1ForwardCAATATACAGACTTATACCAATGAAAACCReverseTGGGATCCTTAAGGTTCATTGTG2ForwardCCAGAGACCTCTGGATTTGCReverseAAGGCACATCTCAAAGTAAAAGC

Molecular distance analysis {#s4-8}
---------------------------

Whole genome sequencing data in [@bib22] and [@bib46] were used to obtain the average distances for the taxa in this analysis. For each individual, the mean mapping coverage was calculated using ANGSD (0.921--10-g2d8881c) ([@bib31]) with the options '-doDepth 1 -doCounts 1 -minQ 20 -minMapQ 30 -maxDepth 99999'. Then, ANGSD (0.921--10-g2d8881c) was used to extract the consensus sequence for each population accounting for the number of individuals and the average mapping coverage per population (mean + three times standard deviation) with the options "-doFasta 2 -doCounts 1 -maxDepth 99999 -minQ 20 -minMapQ 30 -minIndDepth 5 -setMinDepthInd 5 -minInd X1 -setMinDepth X2 -setMaxDepthInd X3 -setMaxDepth X4'. X1, X2, X3, and X4 are listed below. The consensus sequences of the mouse populations were used to calculate the Jukes-Cantor distances for 10,000 random non-overlapping 25 kbp windows from the autosomes with APE (5.1, 'dist.dna' function) ([@bib49]). The average distances obtained in this way are provided in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}. The expected distances for *Gm13030* were calculated by multiplying the length of the gap-free alignment with the average distances. The observed values were retrieved from the distance table of the alignments using Geneious (11.1.2).

Pairwise substitution comparisons for the *Gm13030* reading frame were calculated with DnaSP ([@bib38]). For this, indels were excluded, stop codons were treated as 21^st^ amino acid following the settings of the program. The results are included in [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}.

PopulationMean coverageStandard deviation of coverageX1X2X3X4*M. mattheyi*23.30483.02815273273*M. spicilegus*25.13824.62715100100*M. spretus*24.88514.2164206854*M. m. castaneus*14.0157.57352537370*M. m. musculus* from Afghanistan17.76858.55131559354*M. m. musculus* from Kazakhstan25.12315.97542074592*M. m. musculus* from Czech Republic24.33814.10342067536*M. m. domesticus* from Iran20.2499.82042050400*M. m. domesticus* from Germany21.63910.51842054432*M. m. domesticus* from France21.49910.02742052416

*Gm13030* knockout line {#s4-9}
-----------------------

*Gm13030* was originally targeted by the Knock-Out Mouse Project (KOMP), but the line was lost. Hence, we obtained a custom-made CRISPR/Cas9 line from the Mouse Biology Program (MBP). The guide RNA was designed to target the beginning of the ORF in the second coding exon and away from the splicing site (genomic DNA target: 5' TGCTCCATCTGCTTTTCAGG 3'). We obtained three mosaic frameshift knockout mice (genetic background: C57BL/6N). Then we mated them with the wildtypes from the same litters to have heterozygous pups, and selected one female and one male with a heterozygous 7 bp deletion (chr4:138,873,545--138,873,551) as the founding pair for further breeding and experiments. Primers for genotyping are listed below.

Allele\
(Fragment length)DirectionSequence (5'\>3')KO\
(502 bp)ForwardCCTACCACATTGGGGCCATCReverseTACAAGCCATAAAACCTCCTGGATWT\
(353 bp)ForwardTTTTCTGCTCCATCTGCTTTTCAReverseAGTCACAGAGAAGGGGACGA

Whole genome sequencing of the founding pair and off-target analysis {#s4-10}
--------------------------------------------------------------------

The genomic DNAs from the founding pair were purified with salt precipitation. Then the samples were prepared with Illumina TruSeq Nano DNA HT Library Prep Kit (Catalog no. FC-121--4003), and sequenced on HiSeq 2500 with TruSeq PE Cluster Kit v3-cBot-HS (Catalog no. PE-401--3001) and HiSeq Rapid SBS Kit v2 (500 cycles) (Catalog no. FC-402--4023). The reads were 2 × 250 bp in order to have good power to detect indels.

We followed GATK Best Practices ([@bib62]) to call variants. Specifically, we mapped the reads to mouse genome GRCm38 ([@bib65]; [@bib69]) with BWA (0.7.15-r1140) ([@bib37]), and marked duplicates with Picard (2.9.0) (<http://broadinstitute.github.io/picard>), and realigned around the indels founded in C57BL/6NJ line ([@bib25]) with GATK (3.7), and recalibrated base quality scores with GATK (3.7) using variants founded in C57BL/6NJ line ([@bib25]) to get analysis-ready reads. We assessed coverage with GATK (3.7) and SAMtools (1.3.1) ([@bib34]), and the coverage of female was 35.48 X and the one of male was 35.09 X. High coverages also provided good power to detect indels. We called variants with GATK (3.7), and applied generic hard filters with GATK (3.7): \"QD \<2.0 \|\| FS \>60.0 \|\| MQ \<40.0 \|\| MQRankSum \<−12.5 \|\| ReadPosRankSum \<−8.0 \|\| SOR \> 3.0' for SNVs and 'QD \<2.0 \|\| FS \>200.0 \|\| ReadPosRankSum \<−20.0 \|\| SOR \> 10.0' for indels. We found 80375 SNVs and 73387 indels in the female and 81213 SNVs and 71857 indels in the male.

347 potential off-target sites were predicted on <http://crispr.mit.edu:8079/> based on mouse genome mm9. 343 of them still existed in mouse genome mm10 (GRCm38) after converting by liftOver (26 Jan. 2015) ([@bib26]), and the four missing sites were ranked low anyway: 131, 132, 143, and 200. GATK (3.7) was used to look for variants found in the whole genome sequencing in the 100 bp regions around the 343 sites. In addition, the reads mapped to the regions around the top 20 sites were manually checked in both samples.

RNA-Seq and data analysis {#s4-11}
-------------------------

The oviducts of 10--11 weeks old females from the *Gm13030* line were carefully collected and immediately frozen in liquid nitrogen. Then, total RNAs were purified using QIAGEN RNeasy Microarray Tissue Mini Kit (Catalog no. 73304), and prepared using Illumina TruSeq Stranded mRNA HT Library Prep Kit (Catalog no. RS-122--2103), and sequenced using Illumina NextSeq 500 and NextSeq 500/550 High Output v2 Kit (150 cycles) (Catalog no. FC-404--2002). All procedures were performed in a standardized and parallel way to reduce experimental variance.

Raw sequencing outputs were converted to FASTQ files with bcl2fastq (2.17.1.14), and reads were trimmed with Trimmomatic (0.35) ([@bib5]). Only paired-end reads left were used for following analyses. We mapped the trimmed reads to mouse genome GRCm38 ([@bib65]; [@bib69]) with HISAT2 (2.0.4) ([@bib28]) and SAMtools (1.3.1) ([@bib37]), and took advantage of the mouse gene annotation in Ensembl (Version 86) by using the `--ss` and `--exon` options of `hisat2-build`. We counted fragments mapped to the genes annotated by Ensembl (Version 86) with HTSeq (0.6.1p1) ([@bib2]), and performed differential expression analysis with DESeq2 (1.14.1) ([@bib40]). Principle component analysis and hierarchical clustering with Euclidean distance and complete agglomeration method on the variance stabilized transformed fragment counts were also performed using DESeq2 (1.14.1) to assign the 24 samples into three clusters.

Droplet digital PCR (the quantitative PCR assay) {#s4-12}
------------------------------------------------

The relative expression levels of three *Dcpp* genes (*Dcpp1*, *Dcpp2*, and *Dcpp3*) in the six cluster 1 samples of the oviducts were further validated by droplet digital PCR. For each sample, 20 µl first strand cDNA solution was obtained using the Thermo Scientific RevertAid First Strand cDNA Synthesis Kit (Catalog no. K1622) by targeting poly-A mRNAs with oligo dT primers from 1 μg RNAs. Then the cDNA samples were diluted with water 1:400 for the PCR reactions. The information of probes and primers for three *Dcpp* genes, and *Uba1* (the reference gene) are listed below. The sequences of the probe and primers for *Dcpp* genes were carefully designed to target all three genes at the same time. All PCR reactions were run with the same master mix and in the same plate. The PCR reaction mixture was prepared from 12.5 μL Bio-Rad ddPCR Supermix for Probes (Catalog no. 1863010), 1.25 μL oligo mix (5 μM probes, 18 μM forward primers, and 18 μM reverse primers) for *Dcpp* genes, 1.25 μL oligo mix for *Uba1*, and 10 μL cDNA dilution. The oil droplets containing 20 μL of the reaction mixture for each sample were generated by Bio-Rad QX100 Droplet Generator (Catalog no. 1863002). After droplet generation, the plate was sealed with a pierceable foil heat seal using Bio-Rad PX1 PCR Plate Sealer (Catalog no. 1814000) and then placed on a thermal cycler for amplification. The thermal cycling conditions were: 95°C for 10 min (one cycle), 94°C for 30 s and 56°C for 60 s (40 cycles), 98°C for 10 min (one cycle). After PCR, the 96-well PCR plate was loaded into Bio-Rad QX100 Droplet Reader (Catalog no. 1863003) which reads the signals in the droplets. Raw data were analyzed with Bio-Rad QuantaSoft analysis software provided with the Bio-Rad QX100 Droplet Reader. The relative expression level of *Dcpp* genes in each sample was calculated by dividing the concentration of *Dcpp* genes by the concentration of *Uba1*. For each sample, two independent technical replicates were performed.

GeneOligo5' modificationSequence (5'\>3')3' modificationThree\
*Dcpp* genesProbeFAMGGACGGTCAAGTGTATGGCTBHQ1Forward primerGATTATCATGGTCCAGAAGTTGGAReverse primerATGTGCTCTTCCTTAGACAGTCTG*Uba1*ProbeHEXCTGAACCTCTTGCTGCACCTBHQ2Forward primerGAAGATCATCCCAGCCATTGReverse primerTTGAGGGTCATCTCCTCACC

Fertility test {#s4-13}
--------------

In addition to using the fertility data from the stock breeding of the *Gm13030* animals, dedicated mating pairs were set up for the fertility test. The female and male in each pair were 8--9 weeks old when the mating was started. All the males were wildtype, and 10 females were homozygous knockout and the other 10 were wildtype. The time (days) until having the first and second litters, the numbers of pups of the first and second litters, and whether the pups were eaten later for each mating pair were carefully observed and recorded by animal caretakers who were blind for the genotypes. [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"} provides the details of the mice, the individual phenotype scores and the notes on the losses of litters, both for the stock breeding, as well as the specifically set up pairs.
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Thank you for submitting your article \"Studying the dawn of de novo gene emergence in mice reveals fast integration of new genes into functional networks\" for consideration by *eLife*. Your article has been reviewed by four peer reviewers, including George H Perry as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Detlef Weigel as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Douglas B Menke (Reviewer \#4).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

You present a knockout study of three putative mouse lineage-specific de novo (not originating from duplication) emergent protein-coding genes, with an integrative transcriptomic and phenotypic analysis. The reviewers praised the aims of the study; this is a potentially fundamentally insightful research program into the functional mechanics of an important evolutionary process that has never previously been studied at nearly this depth in vertebrates. However, we also collectively identified several significant limitations of the current study design and presentation of the manuscript, some of which could potentially be addressed in a revision, although included among the comments is one request for new experimental data that may not be feasible in a reasonable timeframe (but we choose to present the request and the option, in case something can be done in a cell line or in case additional data are already in hand). For another major concern, related to the specificity of two of the three knockouts, we suggest a revised manuscript presentation that would focus on the third knockout (otherwise, updating and repeating the experiments for the first two knockouts would be well beyond a reasonable scope of revision; although note that following a straightforward analytical verification, we suggest that one of these two experiments could still be secondarily described and discussed in the paper). We very much hope that you will consider such a strategy. If you choose to address our essential revisions and resubmit your manuscript to *eLife*, a thorough re-evaluation would be required since the perceived definitiveness of the results could change depending on the revised results.

Essential revisions:

1\) For two of the gene knockout models used for this study, Udng1 and Udng2, the introduced mutations are not small and they overlap and/or are nearby different annotated transcripts. While the specific details and genomic contexts are not provided by the authors (this information should be provided and illustrated in the revision, and carefully discussed), for example the Undg1 knockout mutation used in this study is a deletion \>3kb that also removes part of the annotated ORF *A930004D18Rik*. Udng2 is located directly upstream of the zinc finger protein encoding Zpf169. Therefore, based on current results it is uncertain whether reported effects are explained by the knockout of Udng1 and 2, knockout of (in one case) the overlapping transcript, removal of functional regulatory sequence for neighboring transcripts, or combinations thereof.

2\) The CRISPR/Cas9 induced Udng3 knockout is a 7bp deletion, less likely than the Udng1 and 2 knockouts to have incidental effects on the expression of other genes which could instead explain the findings. We suggest that the authors focus the manuscript on Udng3 primarily, but with two additional requests.

i\) Verify perturbed Dcpp expression with Udng3 knockout by an independent experimental analysis (this is the additional experimental requirement mentioned above). The knockout effects on expression levels of Dcpp family genes, alongside the interesting discussion context of the pseudogenization of both Udng3 and Dcpp3 in M. m. domesticus, are potentially exciting and valuable components of the study, but one that reviewers determined should be verified given questions about other results.

ii\) Verify that the expression levels of genes neighboring Udng3 are not affected by the 7 bp deletion.

3\) If desired, more speculative results on Udng2 could still be offered secondarily, as long as the authors verify that expression levels of the neighboring zinc finger gene are not altered by the deletion.

4\) The manuscript should be revised (from the interpretation through to the discussion) to acknowledge that prior to the origin of these ORFs, the non-coding sequences might have had some function and, in fact, that any such ancestral non-coding function might still exist.

5\) The phenotyping and behavioral study designs, data, and results are under-reported, and the reviewers raised questions about the statistical analyses performed on these data. How many (and which specific) morphological phenotypes and behavioral traits were measured and tested for each knockout experiment? What were the methods/experimental designs for how each measurement was collected or observation recorded? Importantly, the authors should introduce a multiple test-correction framework and revise their discussion of the results accordingly. Please also provide the individual-level data for each variable tested.

6\) A specific concern was raised about the reproductive phenotype highlighted from the Udng3 experiment, which needs to be addressed. Specifically, a large timing difference between the birth of the first and second litters (23 days for KO vs 36 for WT) is reported. Yet WT females often ovulate within a day of giving birth; if a male is present, mating can produce a second litter within 21 days. If the female does not ovulate or mating is not successful, then ovulation is suppressed while the female is lactating, causing a substantial delay in the timing of the next pregnancy. Given the established non-continuous nature of pregnancy intervals in this model system, it is unclear that the authors have robustly identified a reproductive phenotype from these data.

7\) The evolutionary analysis of gene gain needs to be strengthened beyond the current \'intact/not intact\' assessment presented in Figure 2, and should also include an expanded set of available genomes in the comparison. At present it is assumed that the functional genes emerged in the *M. musculus* lineage following divergence from common ancestors shared with other studied taxa, yet without more detailed analysis it remains possible that these genes emerged earlier and then accumulated pseudogenizing mutations in the other lineage(s). Here, the analysis should include the specific pattern of ancestral vs. derived mutations that open up (or maintain as closed) the reading frame.

In addition, the authors use an older version of the mouse genome annotation, Ensembl 80 (from 2015), while the current is Ensembl 95. Between these two versions a new set of mouse species annotations have become available, which should be included in the revised Figure 2 analysis and will help inform the study. For example, the 3 genes studied in this paper have annotated protein coding orthologs in Mus caroli (3 MY divergence with *M. musculus*) and M. Pahari (6 MY), suggesting earlier emergence timing for these genes than currently presented in the paper.

8\) In the initial analysis of the ENCODE RNA-seq data a very low transcription threshold of 0.1 FPKM was used, whereas most mouse protein coding genes have expression levels higher than 5 FPKM in the 35 tissues investigated. With such a low threshold, pervasive transcription of much of the genome could potentially be observed. The authors should comment on this issue, their choice of threshold, and consider further analyses to justify / confirm that transcripts would not be spuriously identified.

The process used to select the three genes for detailed study from among the larger set of candidates should be detailed more precisely, especially given that the expression levels for two of the loci are relatively low. Were these the only three candidates meeting all of the (general) criteria mentioned? Are here any additional data (e.g. antibody staining of tissues) that protein products are produced?

9\) The transcriptome analysis from the knockout experiments should be strengthened. Especially, it would be more convincing that the magnitude of the observed differences and the specific results themselves do not simply reflect experimental noise (i.e. on a genomic scale, sets of differentially expressed transcripts are always observed even between sets of technical replicates) if the authors were to compare two sets of control experiments to each other, or for example to randomly select WT and KO sample size-matched sets of individuals from the whole sample (which can then be permuted), and evaluate accordingly.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Studying the dawn of de novo gene emergence in mice reveals fast integration of new genes into functional networks\" for consideration by *eLife*. Your article has been reviewed by six peer reviewers, including George H Perry as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Detlef Weigel as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Douglas B Menke (Reviewer \#4); Julian Christians (Reviewer \#5).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Your revised manuscript was first reviewed by the four reviewers of the original submission. While stark improvements on multiple fronts were noted, three major concerns -- one related to each of the three de novo gene experiments -- remained. These concerns are detailed below. In two cases, we sought specific input from reviewers with appropriate expertise to help finalize our decision.

First, the 3kb Undg1 knockout also removes two strongly conserved non-coding sequences (e.g. chr2:18,026,405-18,026,620 of the mouse mm10 assembly), the potentially-relevant functional consequences of which are not mentioned. Concern about the inability of this experimental design to account for the consequences of removal of DNA sequence involved in gene regulatory processes was mentioned briefly in the previous decision letter, with deeper investigation now revealing these specific conserved sequences.

As an editor, while I appreciate that efficient techniques to effectively limit knockout footprints have only recently become practicable, the appropriate interpretative approach should still be to attribute any observed phenotypic consequences to simultaneously affected, deeply-conserved sequences than to the absence of a protein encoded by a de novo gene. This null and conservative hypothesis should only be rejected alongside convincing evidence to the contrary. In the absence of any understanding of the biological functions of the de novo gene (i.e. one of the goals of this study) this is quite a difficult proposition within the bounds of the present experiment. Since your original interpretations may ultimately be proven correct, and because these experimental results could be a key part of that process and of developing understandings of de novo gene evolution, I still encourage the inclusion of the Undg1 experiment as a secondary and tentative result, with caveats leading the way.

Second, the proximity of the Undg2 knockout to the zinc finger protein-encoding Zpf169 gene led to concern expressed in the previous decision letter that expression levels of this gene might be affected, which could thus be a more likely explanation for the phenotypic observations. We had requested your evaluation of Zpf169 expression levels from the RNA-seq data. Indeed, Zpf169 expression is significantly reduced (with approximately 0.75-fold expression) in the Undg2 knockout experiment. In the revision, you conclude that an expression difference of this magnitude would be very unlikely to result in the observed phenotypic effects because Zpf169 is a KRAB-Zn-finger protein, family members of which bind to transposable elements to silence them. After seeking further input, we conclude that this statement is unwarranted. Even if Zpf169 is ultimately confirmed to be TE-controlling, such loci can have marked transcriptome effects across various developmental stages and cell types.

Third, your revised analysis of the reproductive phenotype data from the Undg3 targeted knockout experiment was considered a substantial improvement. An additional reviewer described the revised analytical approach as appropriate and considered the results compelling, helping to resolve our remaining questions concerning this experiment.

Based on this evaluation process, I am recommending that your manuscript be considered further for publication if you choose to make the following essential revisions. The first three essential revision points are summary conclusions based on the above detailed report of the review process.

Essential revisions:

1\) Focus the manuscript on the Undg3 experiments and results.

2\) Remove the Undg2 knockout experiment and results from the main text and figures of the paper. If presented in supplementary information to help support the description of the overall process of the investigation, the strong (and null hypothesis) possibility that phenotypic observations are explained by the Zpf169 expression change should be used to help frame the presentation and discussion.

3\) The Undg1 knockout experiment and results could be presented as secondary in the main text or as part of the supplementary information. In either case the approach described above should be followed.

4\) The selection process for the de novo genes chosen for detailed examination (e.g. as discussed in the responses to reviewer comments) should be presented more fully in the main text of the paper.

5\) Figure 2 should differentiate between the total absence of a gene from the presence of a disabled version of the gene.

\[Editors\' note: a further round of revisions were suggested.\]

Thank you for resubmitting your work entitled \"A de novo evolved gene in the house mouse regulates female pregnancy cycles\" for further consideration at *eLife*. Your revised article has been evaluated by Detlef Weigel (Senior Editor), George Perry (Reviewing Editor), and four reviewers.

You extensively revised your manuscript in response to reviewer and editor feedback, and when I read the manuscript I am impressed with the current approach and results. I see a thorough, multi-step, novel investigation into a difficult-to-study phenomenon (de novo gene emergence), with analyses spanning from genome-scale to locus specific, and approaches across the spectrum from transcriptomic to detailed molecular biology to in vivo.

While the reviewers were generally pleased with how the paper was revised, there remains some skepticism concerning the ultimate in vivo reproductive phenotype (and they also raise some specific concerns and questions, including on the newly-presented data, that require your attention; see below). However, I do recognize the multiple in vitro results that altogether help strengthen that case, and I (George Perry) take responsibility for the decision to proceed with the understanding that (as always) future experiments may further clarify the biology. Overall, I conclude that the multiple layers of valuable insight that will provided by this eventual publication are likely to represent a substantial advance in this field of research, and thus I would encourage you to consider the below remaining issues to be addressed before acceptance.

Essential revisions from reviewer comments:

1\) A data reporting / statistical inconsistency was identified by that needs to be addressed: The text states that they set up 10 mating pairs with homozygous mutant females and 10 mating pairs with WT females. However, Figure 5 (and the supplemental data) show that they actually collected data from 16 mating pairs with homozygous females, 13 matings pairs with WT females, and 7 mating pairs with heterozygous females. The p-value of 0.042 was obtained by combining the WT and Het data and comparing it against the homozygous mutant data. I get the same p-value (0.042) when I used the same statistical test used by the authors (two-tailed Wilcoxon rank sum test). When only WT is compared against mutant, the p-value is 0.12.

2\) The authors have observed that deletion of Gm13030 affects gene expression in only one phase of the estrous cycle (when there is high progesterone receptor and estrogen receptor 1 expression, and low G protein-coupled estrogen receptor 1 expression). How does this phase correspond to the period between ovulation and implantation (when the deletion would presumably exert its effect)?

3\) Subsection "Transcriptome and phenotype changes": \"We identified a possible direct link between the identified phenotype of a shorter gestation length in the knockouts\" Gestation length (i.e., between fertilization and birth) was not measured; a difference was observed in the timing between the birth of the first and second litter.

4\) The authors suggest that Gm13030 may be involved in a parent-offspring conflict of interest, i.e., \"this is a system where a selfish tendency of embryos in expense of the resources of the mothers could develop.\" (subsection "Transcriptome and phenotype changes" and related statements in this section and "Male bias versus female bias"). However, it does not appear that there is a conflict of interest here, and it is not clear how such a conflict might work. The pups that are born earlier are more likely to be cannibalized/ neglected by the mother, in addition to being more likely to compete with older siblings. Thus, there is potentially a trade-off between having a second litter quickly (more reproduction sooner) vs waiting (when second litters will be more likely to survive), but this isn\'t a conflict between parent and offspring. Parent-offspring conflicts generally involve situations where individual offspring would like the parent to invest more in them, whereas the parent would like to preserve resources for other offspring. While traveling down the oviduct, it is not clear how conceptuses could extract more resources from the mother in a way that compromised the mother\'s future reproduction without impacting their own survival.

5\) Provide a clearer justification/statement explaining why you selected Gm13030 for detailed analysis from the broader set of candidates and/or why you desired to study the function of a gene expressed in the female reproductive tract.

6\) Figure 3 describes the expected number of substitutions expected between species. However, the number of coding and non-coding substitutions should be provided separately to support the statement \"there is no bias towards coding mutations\".

10.7554/eLife.44392.024

Author response

We appreciate the decision and the suggestion to put less emphasis on two of the three genes studied. We have carefully considered this, but in balance, we believe that the breadth of the results for all three genes is sufficiently broad that they should also be fully reported. However, we have added additional analyses and descriptions for these genes. In addition, we would like to point out that our knockout method for Udng1 and Udng2 was the most widely used method before CRISPR/Cas9 occurring which allowed the discovery of lots of true knowledge, and it is still valuable now due to that CRISPR/Cas9 also has its own limitation. Besides, previous functional studies of de novo genes were mainly using RNAi knockdown method, our knockout procedure for Udng1 and Udng2 is already one step forward.

> Essential revisions:
>
> 1\) For two of the gene knockout models used for this study, Udng1 and Udng2, the introduced mutations are not small and they overlap and/or are nearby different annotated transcripts. While the specific details and genomic contexts are not provided by the authors (this information should be provided and illustrated in the revision, and carefully discussed), for example the Undg1 knockout mutation used in this study is a deletion \>3kb that also removes part of the annotated ORF A930004D18Rik. Udng2 is located directly upstream of the zinc finger protein encoding Zpf169. Therefore, based on current results it is uncertain whether reported effects are explained by the knockout of Udng1 and 2, knockout of (in one case) the overlapping transcript, removal of functional regulatory sequence for neighboring transcripts, or combinations thereof.

We apologize that we have not provided sufficiently clear details on the genes and the knockouts. We have now added appropriate sketches and further details. We have also clarified the annotation for Udng1 in the database. Note that we cannot confirm the annotated first exon of *A930004D18Rik* (Udng1) from any of the available transcriptome samples. Its annotation appears to be derived from an EST and a cDNA from retina sample. But we realized now that the new transcript that we had reconstructed has the capacity to code for an ORF that we had not considered before. It turns out that the ribosome profiling data support the translation of this ORF, as well as the other ORF that we had analyzed before. The knockout construct deletes both ORFs. We have now added all these descriptions in detail.

For Udng2, we had indeed failed to point out that it is an example for a de novo gene having apparently emerged from a bidirectional promotor and we have added this information now. It is known that this is one of the emergence mechanisms for novel transcripts.

*Zfp169* (chr13:48,487,647-48,513,451) is indeed expressed lower in the Udng2 knockout mice (0.78 fold in males, 0.766 fold in females). However, *ZFP169* belongs to the KRAB-Zn-finger proteins, which bind to transposable elements to silence them. Hence, it is very unlikely that the small expression difference could cause the effects we see for the Udng2 knockout. We added this information to the text.

> 2\) The CRISPR/Cas9 induced Udng3 knockout is a 7bp deletion, less likely than the Udng1 and 2 knockouts to have incidental effects on the expression of other genes which could instead explain the findings. We suggest that the authors focus the manuscript on Udng3 primarily, but with two additional requests.
>
> i\) Verify perturbed Dcpp expression with Udng3 knockout by an independent experimental analysis (this is the additional experimental requirement mentioned above). The knockout effects on expression levels of Dcpp family genes, alongside the interesting discussion context of the pseudogenization of both Udng3 and Dcpp3 in M. m. domesticus, are potentially exciting and valuable components of the study, but one that reviewers determined should be verified given questions about other results.

We note that our originally presented results had already provided a kind of replicated evidence in the sense that all three *Dcpp* genes were affected in the same way. We have now added a quantitative PCR experiment to confirm this (data are summarized in Figure 4---figure supplement 1).

> ii\) Verify that the expression levels of genes neighboring Udng3 are not affected by the 7 bp deletion.

The expression differences for the neighboring genes are indeed only very minor and not significant (fold changes: upstream gene *Pla2g2e* = 0.95, downstream gene *Pla2g5* = 1.06). We added a note to to the text that these genes are not among the differentially expressed genes.

> 3\) If desired, more speculative results on Udng2 could still be offered secondarily, as long as the authors verify that expression levels of the neighboring zinc finger gene are not altered by the deletion.

As pointed out above, the *ZFP169* expression is slightly lowered in the knockouts, but the gene is not expected to act as a regulator of transcription.

> 4\) The manuscript should be revised (from the interpretation through to the discussion) to acknowledge that prior to the origin of these ORFs, the non-coding sequences might have had some function and, in fact, that any such ancestral non-coding function might still exist.

This is probably true for many genes. But we acknowledge this now and emphasize that the genes are predicted to function via their proteins. We also discuss specifically the possibility (and evidence) for prior emergence as non-coding RNAs. Further we have removed sections that relate to the question of protein function. And we have added a section in the discussion addressing the question of coding versus non-coding RNAs.

> 5\) The phenotyping and behavioral study designs, data, and results are under-reported, and the reviewers raised questions about the statistical analyses performed on these data. How many (and which specific) morphological phenotypes and behavioral traits were measured and tested for each knockout experiment?

We had indeed done several other pre-tests on smaller number of animals, mostly on the Udng2 line, to see whether any of them would show a tendency. We then continued only with the test that showed a tendency and used double the number of animals to confirm this tendency. Now we fully added this information in the text, including a new table (Table 4) and a new supplemental table (Table 4---source data 1). We have also improved our statistical analysis by adding the analysis only using the expanded samples. Last but not least, we added a statement in the text that we are following the RRR principles of animal experiments in reducing them to the minimally necessary numbers, even with the risk that we might have missed a phenotype.

> What were the methods/experimental designs for how each measurement was collected or observation recorded? Importantly, the authors should introduce a multiple test-correction framework and revise their discussion of the results accordingly. Please also provide the individual-level data for each variable tested.

We have further updated the Materials and methods section. Now we have added also the multiple testing corrections for all phenotyping results, and revised the text accordingly. The individual level data were included in a supplementary file, but this was not very clear. We have now reorganized the supplements to make this clearer.

> 6\) A specific concern was raised about the reproductive phenotype highlighted from the Udng3 experiment, which needs to be addressed. Specifically, a large timing difference between the birth of the first and second litters (23 days for KO vs 36 for WT) is reported. Yet WT females often ovulate within a day of giving birth; if a male is present, mating can produce a second litter within 21 days. If the female does not ovulate or mating is not successful, then ovulation is suppressed while the female is lactating, causing a substantial delay in the timing of the next pregnancy. Given the established non-continuous nature of pregnancy intervals in this model system, it is unclear that the authors have robustly identified a reproductive phenotype from these data.

We appreciate that the reviewer pointed out the non-continuous nature of pregnancy intervals. We have now specifically analyzed our data for this. Our data show indeed the non-continuous nature of the time to the next litter. It is either smaller than or equal to 25 days (early group) or larger than or equal to 35 days (late group). We have now added additional text and an additional figure (Figure 5) to make this point clear.

> 7\) The evolutionary analysis of gene gain needs to be strengthened beyond the current \'intact/not intact\' assessment presented in Figure 2, and should also include an expanded set of available genomes in the comparison. At present it is assumed that the functional genes emerged in the *M. musculus* lineage following divergence from common ancestors shared with other studied taxa, yet without more detailed analysis it remains possible that these genes emerged earlier and then accumulated pseudogenizing mutations in the other lineage(s). Here, the analysis should include the specific pattern of ancestral vs. derived mutations that open up (or maintain as closed) the reading frame.

We acknowledge that we have too much focused the text on presence-absence descriptions. Further, the sequence alignments originally provided in the data were based on direct PCR and re-sequencing, since short read sequences from genome projects are not fully reliable. We have now added also the genomic information into the alignments (Figure 2---figure supplements 3-6) and redesigned Figure 2. We have also extended the text to make clear that the ORFs could indeed have emerged earlier, but carry partially secondary disabling mutations. Still, rat and *Apodemus* clearly do not show the ORFs, i.e. the genes are very young.

> In addition, the authors use an older version of the mouse genome annotation, Ensembl 80 (from 2015), while the current is Ensembl 95. Between these two versions a new set of mouse species annotations have become available, which should be included in the revised Figure 2 analysis and will help inform the study. For example, the 3 genes studied in this paper have annotated protein coding orthologs in Mus caroli (3 MY divergence with *M. musculus*) and M. Pahari (6 MY), suggesting earlier emergence timing for these genes than currently presented in the paper.

As pointed out above, we added this genomic information now. In addition, we note that although these are denoted as coding orthologs, the Ensembl website (Version 95) lists the reading frames as interrupted:

\>MGP_CAROLIEiJ_T0049751.1 (Udng1 ORF2, *Mus caroli*)

VDRQVTLIFPSSVRMPKSCFKAFL\*LESKL\*LFFIIRK\*L\*AWDEIGQSRNLLIPSKFVN

RCTYYRTGPRVQPVWDPRLAPSATSARCYPILFFSSFFLESTDKHMKTLGSVLHELQLLG

GNPMNEQVKFREVSVYSLSVGAWEHGAADCPWTMAHP

\>MGP_PahariEiJ_T0060766.1 (Udng1 ORF2, *Mus pahari*)

VDRQVTLIFPSSVRGCLNLASRGFYNWKANFYFSLLYVNDCEHGMRLANLRIFSLQQTRG

QVHVLEDWTTRPACVGSTSCIFSDLCSVLSYTFFFLSFLNRLINI\*ELEVSSTNFSFLEE

TL\*MSK\*SSARSQSVPSRLAPGSMGLQTVPGLWHTH

\>MGP_CAROLIEiJ_T0034271.1 (Udng2, *Mus caroli*)

MGKHCTRKQWRNISDVDNK\*SEQRTPLVRNRSGTKQRRESRARPGGQPETKPGPWGNQGS

LSSKDSTKDQRNPQRCSGPFLGRSPNTDSTGHTAAPSQGKSPGENVSGNKGGEEQHLFL\*

GHKAFRVVHNIWKWFHLDRKTRWGP\*AFLVSPKKMQN\*A\*KRSNCLQV

\>MGP_CAROLIEiJ_T0065417.1 (Udng3, *Mus caroli*)

MCRFHLLQAIKPPEKQMEQKTSALGSIMKLSQRHATETTWVFPSQGLRAYLLHPACFHHF

RKEEKPD\*RPANMIYGFDKIHPRSC\*TVLLVQPCLLMLSRDLGPEQLQ\*LQLIPDDITSS

SLSYGSSQNLSQALNFPKHVDTG

(There are no annotated coding orthologs for Udng1 ORF1 in *Mus caroli* and *Mus pahari* in Ensembl 95; there are no annotated coding orthologs for Udng2 and Udng3 in *Mus pahari* in Ensembl 95.)

> 8\) In the initial analysis of the ENCODE RNA-seq data a very low transcription threshold of 0.1 FPKM was used, whereas most mouse protein coding genes have expression levels higher than 5 FPKM in the 35 tissues investigated. With such a low threshold, pervasive transcription of much of the genome could potentially be observed. The authors should comment on this issue, their choice of threshold, and consider further analyses to justify / confirm that transcripts would not be spuriously identified.

This is a continuous issue in the de novo gene research field: new genes are known to be expressed at lower levels, i.e., the thresholds that are used for well conserved genes are not the best to be applied. But we agree that no matter how to select the threshold, it will be artificial, and there is no gold standard. FPKM value itself should not be a cutoff to distinguish real transcripts and transcriptional noise, because even a low expressed transcript could be well supported by reads if the sequencing depth is deep enough. We chose 0.1 as the threshold because we found through manual checking that the mapped RNA-Seq reads from ENCODE data for some low expressed de novo genes (FPKM value between 0.1 and 0.2), including Udng3, and their gene structures are well supported. We also kept minimum usage of this cutoff, *i.e.*, only for the result showed in Figure 1B.

> The process used to select the three genes for detailed study from among the larger set of candidates should be detailed more precisely, especially given that the expression levels for two of the loci are relatively low. Were these the only three candidates meeting all of the (general) criteria mentioned? Are here any additional data (e.g. antibody staining of tissues) that protein products are produced?

Yes, other genes could also have been used, but we had to take a decision. Many considerations went into this decision, a major one was the availability of targeted lines in public resources (EMMA and KOMP). Note that also Udng3 had been targeted, but could not be revived. This is why we then decided to use a CRISPR approach.

There are no antibody data available for any of these genes. But by today´s standards, an antibody staining would anyway be seen very critically, due to the possibility of unaccounted cross-reactions.

> 9\) The transcriptome analysis from the knockout experiments should be strengthened. Especially, it would be more convincing that the magnitude of the observed differences and the specific results themselves do not simply reflect experimental noise (i.e. on a genomic scale, sets of differentially expressed transcripts are always observed even between sets of technical replicates) if the authors were to compare two sets of control experiments to each other, or for example to randomly select WT and KO sample size-matched sets of individuals from the whole sample (which can then be permuted), and evaluate accordingly.

We include now also the permutation analysis as requested to support that our differential expression signals are valid (Figure 3---figure supplement 1). But we need to point out that we have also taken utmost care and experimental effort (much more than usual) to distinguish noise from real signal.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Essential revisions:
>
> 1\) Focus the manuscript on the Undg3 experiments and results.
>
> 2\) Remove the Undg2 knockout experiment and results from the main text and figures of the paper. If presented in supplementary information to help support the description of the overall process of the investigation, the strong (and null hypothesis) possibility that phenotypic observations are explained by the Zpf169 expression change should be used to help frame the presentation and discussion.
>
> 3\) The Undg1 knockout experiment and results could be presented as secondary in the main text or as part of the supplementary information. In either case the approach described above should be followed.

*4) The selection process for the* de novo *genes chosen for detailed examination (e.g. as discussed in the responses to reviewer comments) should be presented more fully in the main text of the paper.*

> 5\) Figure 2 should differentiate between the total absence of a gene from the presence of a disabled version of the gene.

We have followed your advice to concentrate the presentation on only one of the genes (formerly called Udng3, we use now the ENSEMBL designation Gm13030). This has led to a major rearrangement of the manuscript, including a new title, as well as an additional discussion on female-specific genes. Further, material that was previously in the supplementary files has partly been moved into the main text. We have also added a new figure showing the evolutionary tree and substitutions of the gene (Figure 3). Apart of this, we have not included any new analyses.

As discussed with the editors, our only reference to the two other genes is now in the discussion. We plan to do CRSPR knockouts for these to confirm the initial findings and we would hope that these can then be published as a Research Advance to the present paper.

\[Editors\' note: a further round of revisions were suggested.\]

*While the reviewers were generally pleased with how the paper was revised, there remains some skepticism concerning the ultimate* in vivo *reproductive phenotype (and they also raise some specific concerns and questions, including on the newly-presented data, that require your attention; see below). However, I do recognize the multiple* in vitro *results that altogether help strengthen that case, and I (George Perry) take responsibility for the decision to proceed with the understanding that (as always) future experiments may further clarify the biology. Overall, I conclude that the multiple layers of valuable insight that will provided by this eventual publication are likely to represent a substantial advance in this field of research, and thus I would encourage you to consider the below remaining issues to be addressed before acceptance.*

We appreciate your positive decision and careful comments. After revisions following your suggestions, we are submitting the revised manuscript, with detailed point-to-point responses.

We submit the revised version of the manuscript plus an annotated version that shows all the changes. In addition, we replaced Figure 3 with a slightly optimized version (the contours in the tree were optimized), as well as a new file as Figure 3---figure supplement 3 which is a table that shows the statistics for the coding/noncoding substitutions.

> Essential revisions from reviewer comments:
>
> 1\) A data reporting / statistical inconsistency was identified by that needs to be addressed: The text states that they set up 10 mating pairs with homozygous mutant females and 10 mating pairs with WT females. However, Figure 5 (and the supplemental data) show that they actually collected data from 16 mating pairs with homozygous females, 13 matings pairs with WT females, and 7 mating pairs with heterozygous females. The p-value of 0.042 was obtained by combining the WT and Het data and comparing it against the homozygous mutant data. I get the same p-value (0.042) when I used the same statistical test used by the authors (two-tailed Wilcoxon rank sum test). When only WT is compared against mutant, the p-value is 0.12.

We apologize that this was a bit confusing, since we combined the data from two breeding rounds into one table and had described only one of them in the Materials and methods. But as described in the text, we analyzed first the data that we had already obtained from the normal stock breeding (coded under UC in the table, and they include also heterozygous animals). To confirm them, we set up another 10 dedicated breeding pairs (coded under WT and KO in the table). The P-Value was then indeed calculated across both sets of results, using a test that can be applied for such a data structure. We have clarified this in the text and the Materials and methods.

> 2\) The authors have observed that deletion of Gm13030 affects gene expression in only one phase of the estrous cycle (when there is high progesterone receptor and estrogen receptor 1 expression, and low G protein-coupled estrogen receptor 1 expression). How does this phase correspond to the period between ovulation and implantation (when the deletion would presumably exert its effect)?

This is the period of proestrus or the starting of estrus, i.e., when the females start to become receptive for implantation. We have clarified this in the text.

> 3\) Subsection "Transcriptome and phenotype changes": \"We identified a possible direct link between the identified phenotype of a shorter gestation length in the knockouts\" Gestation length (i.e., between fertilization and birth) was not measured; a difference was observed in the timing between the birth of the first and second litter.

We corrected this into "interval to second birth".

> 4\) The authors suggest that Gm13030 may be involved in a parent-offspring conflict of interest, i.e., \"this is a system where a selfish tendency of embryos in expense of the resources of the mothers could develop.\" (subsection "Transcriptome and phenotype changes" and related statements in this section and "Male bias versus female bias"). However, it does not appear that there is a conflict of interest here, and it is not clear how such a conflict might work. The pups that are born earlier are more likely to be cannibalized/ neglected by the mother, in addition to being more likely to compete with older siblings. Thus, there is potentially a trade-off between having a second litter quickly (more reproduction sooner) vs waiting (when second litters will be more likely to survive), but this isn\'t a conflict between parent and offspring. Parent-offspring conflicts generally involve situations where individual offspring would like the parent to invest more in them, whereas the parent would like to preserve resources for other offspring. While traveling down the oviduct, it is not clear how conceptuses could extract more resources from the mother in a way that compromised the mother\'s future reproduction without impacting their own survival.

We agree that this argument was presented a bit too superficially. It is not the embryo that exerts the conflict, but the selfish interest of *Dcpp* genes. As described in the text, they are induced by the embryo passage and stronger expression favors embryo implantation. In a wildtype situation an early birth could indeed be an advantage, given the high predation pressure, i.e., the mother does often not live long enough for a second birth. But this is rather speculative, i.e., we have corrected only the wording with respect to pointing out that it is the selfish nature of *Dcpp* expression that causes the conflict.

> 5\) Provide a clearer justification/statement explaining why you selected Gm13030 for detailed analysis from the broader set of candidates and/or why you desired to study the function of a gene expressed in the female reproductive tract.

We had related to this in the Introduction: "There is generally a tendency to focus on male testis effects for newly evolved genes. However, considering that the females have much more complex reproduction than that in other organisms, including the morphology, physiology and behavior responding to mating choice, pregnancy, and parenting, de novo genes in mammals should also be expected to have a function in female-specific organs and affect female fertility and reproductive behavior as well." which provides the framework for the choice of the gene. We have now modified this statement slightly and added: "From this list, we have then chosen a gene specifically expressed in the female reproductive system to address the question of the role of de novo gene evolution in this as yet little studied context."

> 6\) Figure 3 describes the expected number of substitutions expected between species. However, the number of coding and non-coding substitutions should be provided separately to support the statement \"there is no bias towards coding mutations\".

The expected number of substitutions refers to near neutral substitutions derived from whole genome comparisons, i.e., independent of them being coding or non-coding. We have clarified this. We have now also added a supplementary Table (Figure 3---figure supplement 3) that lists in all relevant pairwise comparisons the coding and non-coding substitutions for the given reading frame, as well as the corresponding P-Values (which are all non-significant).

[^1]: International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
